In a preclinical model of lung cancer, it was demonstrated that MDSC-associated IDO modulates the in vivo and ex vivo differentiation of B regulatory cells (Bregs), an IL-10 producing subset of B cells, found to be reduced in tumor-bearing IDO deficient mice (IDO-/-) (76). This evidence concerns the gene IDO1 and lung cancer.